Fungal infections have been on the rise since COVID-19’s inception, but public health tracking tools, tests, and data systems in the U.S. are not quite where they need to be yet, Tom Chiller, MD, CDC’s head of mycotic diseases, told Becker’s. “We don’t have good surveillance for fungal infections,” Dr. Chiller said. “A lot of […]
Credit: iStock Use of semaglutide 2.4 mg (Wegovy) was associated with a reduction in the risk of major adverse cardiovascular events in the SELECT trial, according to an announcement from Novo Nordisk.1 Announced on August 8, 2023, topline results of the trial indicate once-weekly semaglutide 2.4 mg was associated with a 20% reduction in major […]
image: “Our findings highlight the vital importance of seeking expert opinions from National Cancer Institute-designated cancer centers, especially with rare blood and bone marrow cancers such as MDS,” said Dr. Mikkael Sekeres, chief of Hematology at Sylvester Comprehensive Cancer Center. view more Credit: Photo by Clutch Content Partners MIAMI, FLORIDA (EMBARGOED UNTIL AUG. 8, 2023 AT […]
Cardiovascular diseases (CVD), particularly stroke and ischemic heart disease, remain the most common causes of premature death globally. The high incidence of CVD has been attributed to unhealthy lifestyles and obesity. Several other factors including smoking, adverse lipid profile, and elevated blood pressure also increase the risk of CVD events. In fact, the presence of […]
Credit: boonchai wedmakawand/Getty Images Topline results from the large-scale Semaglutide Effects on Heart Disease and Stroke in Patients with Overweight or Obesity (SELECT) clinical study released today show that the Novo Nordisk obesity drug reduces the risk of major adverse cardiovascular events by 20 percent. The SELECT trial is the first to demonstrate the long-term […]
Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Weight loss jabs can reduce the risk of a heart attack or stroke in obese people with cardiovascular disease by a fifth, researchers claim. Pharmaceutical company Novo Nordisk conducted a five-year study […]
“Our findings highlight the vital importance of seeking expert opinions from National Cancer Institute-designated cancer centers, especially with rare blood and bone marrow cancers such as MDS,” said Dr. Mikkael Sekeres, chief of Hematology at Sylvester Comprehensive Cancer Center. Credit: Clutch Content Partners Blood disorders known as myelodysplastic syndromes/neoplasms (MDS) are difficult to diagnose—and are […]
TALLAHASSEE — The Florida Supreme Court on Monday refused to take up a property insurer’s appeal in a dispute about whether blood should be considered a pollutant under a homeowners’ policy. Justices declined to hear an appeal by Florida Farm Bureau General Insurance Co. in the dispute about whether the policy excluded coverage for cleaning […]
People diagnosed with rare blood and bone marrow cancers like MDS were found to be receiving inappropriate treatments “almost 10% of the time.” Recent research from the Sylvester team and their partners sheds light on the challenges of diagnosing blood diseases, emphasizing the essential collaboration between doctors and pathologists. Diagnosing myelodysplastic syndromes/neoplasms (MDS) – a […]
Apollo Hospitals, Jubilee Hills launches Comprehensive Pediatric care with Apollo Children’s Askari Jaffer Hans News Service | 8 Aug 2023 1:48 PM GMT Highlights Building on its 40-year legacy of clinical excellence, Apollo, the world’s largest vertically integrated healthcare provider has also achieved leadership in managing the specialised healthcare needs of Children. Building on its […]